Home › Groups › Managed Care Learning Network ›

Testing Center
Optimizing Multiple Myeloma Treatment and Supportive Care: Clinical and Cost Considerations for Managed Care
Applying Available Data and Disease Management Programs to Optimize Gout Treatment and Outcomes
Improving Outcomes in Major Depressive Disorder: Advancing Health Plan Performance and Community Health Using NCQA HEDIS® Measures
Case 4: Lilly is a 38-year-old female with multiple myeloma (MM) who achieves a complete response after initial treatment. Nine months later, she relapses and requires treatment for refractory MM
Case 3: HealthGuard Company is a commercial health plan that is conducting an annual review of agents used to treat multiple myeloma (MM). The most anticipated discussion surrounds MM therapy options and their impact on outcomes
Pursuing Type 2 Diabetes Treatment Goals among In-Plan Clinicians and Covered Patients: Payor Strategies for Optimizing Outcomes
Managed Care Strategies for Diminishing the Burden of Dyslipidemia in Patients with Chronic Kidney Disease
Evolving Treatment Landscape for AF-Related Stroke: Strategies to Optimize Anticoagulation and Resource Allocation
Case 1: BeWell Company is a commercial health plan that is conducting an annual review of agents used to treat multiple myeloma (MM). The most anticipated discussion surrounds MM supportive treatments and their ability to improve care and lower costs.
Case 2: Jake is a 62-year-old man who lives with consistent pelvic pain. A recent series of X-rays show multiple metastatic lytic lesions. After further testing, Jake is diagnosed with multiple myeloma (MM).
Case 1—Nick is a 65-year-old high school teacher who has noted problems with erectile dysfunction, weight gain, and fatigue over the past two years.
Improving Outcomes in Major Depressive Disorder: Advancing Health Plan Performance and Community Health Using NCQA HEDIS Measures
Effecting Parity in Quality (EPIQ) 2011: Improving Type 2 Diabetes Outcomes in Underserved Patient Populations
Case 3—Patrick: A 46-year-old hardware store clerk presents with rapid irregular palpitations associated with mild dyspnea.
Case 2: WellOne is a managed care organization with approximately 450,000 commercially-based members. It has long been enrolled in HEDIS, but is currently evaluating its HEDIS compliance and the organization’s depression outcomes.
Case 3: Dan is a 52-year old male who recently suffered from a myocardial infarction. Following the episode he was diagnosed with major depressive disorder.
Case 2: Tara—a 62-year-old female with well-controlled type 2 diabetes and CKD—reports to her physician today to discuss results from of recent laboratory tests.
Case 4: Linda is a 24-year old female who is diagnosed with depression for the second time in less than 3 months. Her physician looks to the options in an effort to find the most suitable antidepressant therapy for Linda.
Case 4—Drug Cost Review: You are part of a health plan and have been asked to review the economic impact of atrial fibrillation management.
Case 4: A managed care organization forms a committee to develop strategies to improve outcomes in patients with CKD and dyslipidemia.
Case 1: Frontline Medical Group is a regional managed care organization that would like to report HEDIS data to improve the quality of care provided to in-plan members suffering from major depressive disorder.
Improving Men’s Health: Optimizing Treatment and Outcomes of Androgen Deficiency Syndromes and Prostate Cancer
Advances in Metastatic Melanoma: Clinical and Cost Benefits of Linking Patients to Appropriate Therapy
Case 1: A regional managed healthcare organization is evaluating which types of cancer to include in its screening initiatives to optimize patient outcomes
Case 2: A regional managed healthcare organization is developing an algorithm for appropriate medical management of metastatic melanoma
Case 3: CK is a 62-year-old retired teacher who presents with a primary melanoma on the right arm near his armpit
Case 4: LP is a 47-year old female insurance examiner who presents with 2 pigmented cutaneous lesions on right leg
Case 2: You are part of a health plan and have been asked to review the management of atrial fibrillation. After reviewing novel treatment options, the committee discusses the potential benefits of incorporating them into their tiered benefit design.
Achieving and Outperforming Type 2 Diabetes HEDIS Measures: A Guide for Managed Care to Provide Clinicians with Tools to Support the Delivery of Consistent High-Quality Care
Case 1: Dr. Chantilly is an internist whose diabetes patients are not maintaining an HbA1c of <7%. He looks to NCQA's Diabetes Recognition Program to help bring better outcomes to his practice.